Deuterated Drugs set to Explode in Patent Battles

Circa 2015 created a flutter of excitement in the pharmaceutical world when scientists unearthed patents filed in the 1970s and found it supporting the claims of a modified drug manufactured in the USA. The SD-809 drug is a deuterated drug that is awaiting the FDA’s approval to get on shelves and help cure palsy in patients affected by Huntington’s chorea. One flagged off, the SD-809 could help physicians lower the dosage of the medicine thanks to the deuterium molecule present in this medicine. Read more [...]
Dr. Nalini Mohan Koutha
Dr. Nalini Mohan Koutha

Dr. Nalini is a Pharmaceutical patent expert and has extensive experience as a technical and Intellectual Property Specialist in Generic Pharmaceutical manufacturing. His quest for analytical thinking extends to his deep interest in philately.


Post a Comment

Your email address will not be published. Required fields are marked *